International Diabetes Federation: IDF Diabetes Atlas. 6th edition. Brussels, Belgium: International Diabetes Federation; 2013. [], [http://www.idf.org/diabetesatlas]
Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MB, Chaieb M, Mahjoub T, Almawi WY: Interleukin-10–592C/A, −819C/T and −1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Clin Endocrinol. 2009, 70: 401-407. 10.1111/j.1365-2265.2008.03337.x.
Article
CAS
Google Scholar
Zhang D, Efendic S, Brismar K, Gu HF: Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus. BMC Med Genet. 2010, 11: 116-10.1186/1471-2350-11-116.
Article
PubMed
PubMed Central
Google Scholar
Freedman BI, Bostrom M, Daeihagh P, Bowden DW: Genetic Factors in Diabetic Nephropathy. Clin J Am Soc Nephrol. 2007, 2: 1306-131. 10.2215/CJN.02560607.
Article
CAS
PubMed
Google Scholar
Blech I, Katzenellenbogen M, Katzenellenbogen A, Wainstein J, Rubinstein A, Harman-Boehm I, Cohen J, Pollin TI, Glaser B: Predicting diabetic nephropathy using a multifactorial genetic model. PLoS One. 2011, 6 (4): e18743-10.1371/journal.pone.0018743.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu ZG, Lanting L, Vaziri ND, Li Z, Sepassi L, Rodriguez-Iturbe B, Natarajan R: Upregulation of angiotensin II type I receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation. 2005, 111: 1962-1969. 10.1161/01.CIR.0000161831.07637.63.
Article
CAS
PubMed
Google Scholar
Tashiro K, Koyanagi I, Saitoh A, Shimizu A, Shike T, Ishiguro C, Koizumi M, Funabiki K, Horikoshi S, Shirato I, Tomino Y: Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and inter-leukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal. 2002, 16: 1-4. 10.1002/jcla.2057.
Article
CAS
PubMed
Google Scholar
Lewis A, Steadman R, Manley P, Craig K, de la Motte C, Hascall V, Phillips AO: Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis, Histol. Histopathol. 2008, 23: 731-739.
Google Scholar
Nyengaard JR, Rasch R: The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia. 1993, 36: 189-94. 10.1007/BF00399948.
Article
CAS
PubMed
Google Scholar
Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes. 1995, 44: 1139-46. 10.2337/diab.44.10.1139.
Article
CAS
PubMed
Google Scholar
Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR: Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in type 2 diabetes mellitus. Diabet Med. 2004, 21: 545-551. 10.1111/j.1464-5491.2004.01200.x.
Article
CAS
PubMed
Google Scholar
Chen S, Ziyadeh FN: Vascular endothelial growth factor and diabetic nephropathy. Curr Diab Rep. 2008, 8: 470-6. 10.1007/s11892-008-0081-3.
Article
PubMed
Google Scholar
Celec P, Hodosy J, Gardlík R, Behuliak M, Pálffy R, Pribula M, Jáni P, Turňa J, Sebeková K: The effects of anti-inflammatory and anti- angiogenic DNA vaccination on diabetic nephropathy in rats. Hum Gene Ther. 2012, 23: 158-166. 10.1089/hum.2011.030.
Article
CAS
PubMed
Google Scholar
Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. Brit Med J. 2003, 327: 557-560. 10.1136/bmj.327.7414.557.
Article
PubMed
PubMed Central
Google Scholar
Kavvoura FK, Ioannidis JPA: Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet. 2008, 123: 1-14. 10.1007/s00439-007-0445-9.
Article
PubMed
Google Scholar
Pettigrew KA, McKnight AJ, Patterson CC, Kilner J, Sadlier DM, Maxwell AP: Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy. J Hum Genet. 2010, 55: 248-251. 10.1038/jhg.2010.15.
Article
CAS
PubMed
Google Scholar
Tregouet DA, Groop PH, McGinn S, Forsblom C, Hadjadj S, Marre M, Parving HH, Tarnow L, Telgmann R, Godefroy T, Nicaud V, Rousseau R, Parkkonen M, Hoverfalt A, Gut I, Heath S, Matsuda F, Cox R, Kazeem G, Farrall M, Gauguier D, Brand-Herrmann SM, Cambien F, Lathrop M, Vionnet N: G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes. Diabetes. 2008, 57: 2843-2850. 10.2337/db08-0073.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ahluwalia TS, Khullar M, Ahuja M, Kohli HS, Bhansali A, Mohan V, Venkatesan R, Rai TS, Sud K, Singal PK: Common Variants of Inflammatory Cytokine Genes Are Associated with Risk of Nephropathy in Type 2 Diabetes among Asian Indians. PLoS One. 2009, 4 (4): e5168-10.1371/journal.pone.0005168.
Article
PubMed
PubMed Central
Google Scholar
Mlynarski WM, Placha GP, Wolkow PP, Bochenski JP, Warram JH, Krolewski AS: Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect. Diabetes. 2005, 54: 3331-3335. 10.2337/diabetes.54.11.3331.
Article
CAS
PubMed
Google Scholar
Buraczynska M, Zukowski P, Wacinski P, Berger-Smyka B, Dragan M, Mozul S: Chemotactic cytokine receptor 5 gene polymorphism: Relevance to microvascular complications in type 2 diabetes. Cytokine. 2012, 58 (2): 213-217. 10.1016/j.cyto.2012.01.007.
Article
CAS
PubMed
Google Scholar
Nakajima K, Tanaka Y, Nomiyama T, Ogihara T, Ikeda F, Kanno R, Iwashita N, Sakai K, Watada H, Onuma T, Kawamori R: RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care. 2003, 26: 892-898. 10.2337/diacare.26.3.892.
Article
CAS
PubMed
Google Scholar
Prasad P, Tiwari AK, Kumar KMP, Ammini AC, Gupta A, Gupta R, Thelma BK: Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet. 2007, 8: 20-10.1186/1471-2350-8-20.
Article
PubMed
PubMed Central
Google Scholar
Zhang D, Ma J, Brismar K, Efendic S, Gu HF: A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study. J Diabetes Complicat. 2009, 23: 265-272. 10.1016/j.jdiacomp.2008.05.004.
Article
PubMed
Google Scholar
Wu LSH, Hsieh CH, Pei D, Hung YJ, Kuo SW, Lin E: Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARγ and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant. 2009, 24: 3360-3366. 10.1093/ndt/gfp271.
Article
CAS
PubMed
Google Scholar
Vionnet N, Tregouët D, Kazeem G, Gut I, Groop PH, Tarnow L, Parving HH, Hadjadj S, Forsblom C, Farrall M, Gauguier D, Cox R, Matsuda F, Heath S, Thevard A, Rousseau R, Cambien F, Marre M, Lathrop M: Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations Strongest Evidence for Association With a Variant in the Promoter Region of the Adiponectin Gene. Diabetes. 2006, 55 (11): 3166-3174. 10.2337/db06-0271.
Article
CAS
PubMed
Google Scholar
Prior SL, Javid J, Gill GV, Bain SC, Stephens JW: The adiponectin rs17300539 G > A variant and nephropathy risk. Kidney Int. 2008, 74: 1361-10.1038/ki.2008.474.
Article
PubMed
Google Scholar
Joo KW, Hwang YH, Kim JH, Oh KH, Kim H, Shin HD, Chung WK, Yang J, Park KS, Ahn C: MCP-1 and RANTES Polymorphisms in Korean Diabetic End-Stage Renal Disease. J Korean Med Sci. 2007, 22: 611-5. 10.3346/jkms.2007.22.4.611.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arababadi MK, Mirzaei MR, Sajadi SMA, Hassanshahi G, Ahmadabadi BN, Salehabadi VA, Derakhshan R, Kennedy D: Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: A study of patients from the southest region of Iran. Inflammation. 2012, 35 (3): 797-802. 10.1007/s10753-011-9376-7.
Article
PubMed
Google Scholar
Mtiraoui N, Ezzidi I, Kacem M, Ben Hadj Mohamed M, Chaieb M, Haj Jilani AB, Mahjoub T, Almawi WY: Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Diabetes Metab Res Rev. 2009, 25 (1): 57-63. 10.1002/dmrr.892.
Article
CAS
PubMed
Google Scholar
Loughrey BV, Maxwell AP, Fogarty DG, Middleton D, Harron JC, Patterson CC, Darke C, Savage DA: An interleukin 1B allele, which correlates with a high Secretor phenotype, is associated with diabetic Nephropathy. Cytokine. 1998, 10 (12): 984-988. 10.1006/cyto.1998.0388.
Article
CAS
PubMed
Google Scholar
Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG: Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complicat. 2003, 17: 1-6. 10.1016/S1056-8727(02)00181-2.
Article
PubMed
Google Scholar
Buraczynska M, Ksiazek P, Gaszczyk IB, Jozwiak L: Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant. 2007, 22: 827-832. 10.1093/ndt/gfl641.
Article
CAS
PubMed
Google Scholar
McKnight A-J, Maxwell AP, Patterson CC, Brady HR, Savage DA: Association of VEGF-1499C[right arrow]T polymorphism with diabetic nephropathy in type 1 diabetes mellitus. J Diabetes Complicat. 2007, 21: 242-245. 10.1016/j.jdiacomp.2006.05.005.
Article
PubMed
Google Scholar
Kim HW, Ko GJ, Kang YS, Lee MH, Song HK, Kim HK, Cha DR: Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients. Nephrology. 2009, 14: 681-688. 10.1111/j.1440-1797.2009.01085.x.
Article
CAS
PubMed
Google Scholar
Ng DP, Nurbaya S, Ye S, Krolewski AS: An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetes. Kidney Int. 2008, 74 (4): 521-527. 10.1038/ki.2008.202.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jahromi MM, Millward BA, Demaine AG: Significant correlation between association of polymorphism in codon 10 of transforming growth factor-β1 T(29) C with type 1 diabetes and patients with nephropathy disorder. J Interf Cytokine Res. 2010, 30 (2): 59-66. 10.1089/jir.2009.0026.
Article
CAS
Google Scholar
Ng DPK, Warram JH, Krolewski AS: TGF- β1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: An investigation of multiple known DNA sequence variants. Am J Kidney Disease. 2003, 41 (1): 22-28. 10.1053/ajkd.2003.50011.
Article
CAS
Google Scholar
Salgado-V A, Martinez JA, Rosas M, Garcia-Mena J, Utrera-Barillas D, Gomez-Diaz R, Pena JE, Parra EJ, Cruz M: Association of polymorphisms within the transforming growth factor-β1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations. Nephrology. 2010, 15: 644-648. 10.1111/j.1440-1797.2010.01302.x.
Article
Google Scholar
Tong Z, Yang Z, Patel S, Chen H, Gibbs D, Yang X, Hau VS, Kaminoh Y, Harmon J, Pearson E, Buehler J, Chen Y, Yu B, Tinkham NH, Zabriskie NA, Zeng J, Luo L, Sun JK, Prakash M, Hamam RN, Tonna S, Constantine R, Ronquillo CC, Sadda S, Avery RL, Brand JM, London N, Anduze AL, King GL, Bernstein PS: Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A. 2008, 105 (19): 6998-7003. 10.1073/pnas.0800454105.
Article
CAS
PubMed
PubMed Central
Google Scholar
Elmarakby AA, Sullivan JC: Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther. 2012, 30: 49-59. 10.1111/j.1755-5922.2010.00218.x.
Article
CAS
PubMed
Google Scholar
Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H: Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. Diabetes. 2009, 58: 2365-2375. 10.2337/db08-1790.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sonezaki K, Maezawa Y, Takemoto M, Kobayashi K, Tokuyama T, Takada-Watanabe A, Simoyama T, Sato S, Saito Y, Yokote K: Alteration of VEGF and Angiopoietins Expressions in Diabetic Glomeruli Implicated in the Development of Diabetic Nephropathy. Advanced Studies Med Sci. 2013, 1: 11-28.
Google Scholar
Zent R, Pozzi A: Angiogenesis in diabetic nephropathy. Semin Nephrol. 2007, 27: 161-171. 10.1016/j.semnephrol.2007.01.007.
Article
CAS
PubMed
Google Scholar
Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, Freedman BI, Dekkers OM, Baelde HJ: Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 2011, 54: 544-553. 10.1007/s00125-010-1996-1.
Article
CAS
PubMed
Google Scholar
Chinoy H, Salway F, Fertig N, Tait BD, Oddis CV, Ollier WE, Cooper RG: Monocyte chemotactic protein-1 single nucleotide polymorphisms do not confer susceptibility for the development of adult onset polymyositis/dermatomyositis in UK Caucacians. Rheumatology. 2007, 46 (4): 604-7. 10.1093/rheumatology/kel359.
Article
CAS
PubMed
Google Scholar
Narvatilova Z: Polymorphisms in CCL2 & CCL5 chemikines/chemokine receptors genes and their association with diseases. Biomed Pap Med Fac Univ Palacky Oloumuc Czech Repub. 2006, 150 (2): 191-204. 10.5507/bp.2006.028.
Article
Google Scholar
Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G, Anderson SA, Walter EA, Stephan KT, Hammer MF, Mangano A, Sen L, Clark RA, Ahuja SS, Dolan MJ, Ahuja SK: Global survey of genetic variation in CCR5, RANTES and MIP-alpha:impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A. 2001, 98: 5199-5204. 10.1073/pnas.091056898.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, Stangassinger M, Luckow B, Gröne HJ, Schlöndorff D: Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5- positive leukocytes. J Am Soc Nephrol. 2001, 12: 1173-1187.
CAS
PubMed
Google Scholar
Skov L, Beurskens FJ, Zachariae CO, Reitamo S, Teeling J, Satijn D, Knudsen KM, Boot EP, Hudson D, Baadsgaard O, Parren PW, van de Winkel JG: IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis. J Immunol. 2008, 181 (1): 669-679. 10.4049/jimmunol.181.1.669.
Article
CAS
PubMed
Google Scholar
Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z: Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J Nephrol. 2007, 20 (4): 444-52.
CAS
PubMed
Google Scholar
Garcia DL, Anderson S, Rennke HG, Brenner BM: Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci U S A. 1988, 85 (16): 6142-6. 10.1073/pnas.85.16.6142.
Article
CAS
PubMed
PubMed Central
Google Scholar
Williams WW, Salem RM, McKnight AJ, Sandholm N, Forsblom C, Taylor A, Guiducci C, McAteer JB, McKay GJ, Isakova T, Brennan EP, Sadlier DM, Palmer C, Soderlund J, Fagerholm E, Harjutsalo V, Lithovius R, Gordin D, Hietala K, Kyto J, Parkkonen M, Rosengard-Barlund M, Thorn L, Syreeni A, Tolonen N, Saraheimo M, Waden J, Pitkaniemi J, Sarti C, Tuomilehto J, Tryggvason K, et al: Association testing of previously reported variants in a large case–control meta-analysis of diabetic nephropathy. Diabetes. 2012, 61 (8): 2187-2194. 10.2337/db11-0751.
Article
CAS
PubMed
PubMed Central
Google Scholar
Myśliwska J, Zorena K, Semetkowska-Jurkiewicz E, Rachoń D, Suchanek H, Myśliwski A: High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Netw. 2005, 16 (2): 117-22.
PubMed
Google Scholar
Wong CK, Ho AW, Tong PC, Yeung CY, Kong AP, Lun SW, Chan JC, Lam CW: Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy. Clin Exp Immunol. 2007, 149 (1): 123-31. 10.1111/j.1365-2249.2007.03389.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nakaoka H, Inoue I: The Winner’s Curse. eLS. 2010, John Wiley & Sons Ltd, Chichester, http://www.els.net[doi: 10.1002/9780470015902.a0022495]., [http://www.els.net]
Google Scholar
Wang FL, Tang LQ, Wei W: The connection between GRKs and various signaling pathways involved in diabetic nephropathy. Mol Biol Rep. 2012, 39 (7): 7717-7726. 10.1007/s11033-012-1608-x.
Article
CAS
PubMed
Google Scholar